Nutrition and Exercise Study to Understand Metabolic Syndrome
1 other identifier
interventional
67
0 countries
N/A
Brief Summary
The purpose of this study is to measure the metabolic and behavioral effects of a 12-week yoga program coupled to health education (HED) compared to HED alone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Jun 2013
Shorter than P25 for phase_2
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2014
CompletedFirst Submitted
Initial submission to the registry
September 6, 2016
CompletedFirst Posted
Study publicly available on registry
September 14, 2016
CompletedJanuary 2, 2017
December 1, 2016
7 months
September 6, 2016
December 30, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Change in insulin resistance
Baseline, 12 weeks, and 24 weeks
Secondary Outcomes (10)
Change in hypertension
Baseline, 12, and 24 weeks
Change in dyslipidemia
Baseline, 12, and 24 weeks
Change in body composition
Baseline, 12, and 24 weeks
Change in diet
Baseline, 12, and 24 weeks
Change in physical activity measured with accelerometers
Baseline, 12, and 24 weeks
- +5 more secondary outcomes
Study Arms (2)
Yoga with health education
EXPERIMENTAL12 week yoga program coupled to standardized health education for weight loss
Health education
ACTIVE COMPARATORStandardized health education for weight loss
Interventions
Education on lifestyle changes for treatment of metabolic syndrome
Training in the practice of yoga for treatment of metabolic syndrome
Eligibility Criteria
You may qualify if:
- Elevated waist circumference (Men greater than 102cm; women greater than 88cm)
- Impaired fasting glucose (100-125 mg/dl)
- Elevated blood pressure (systolic ≥130 and/or diastolic ≥ 85)
- Dyslipidemia (triglycerides ≥150 and/or HDL≤ 40 for men; 50 for women)
- Age ≥ 18
- English speaking
You may not qualify if:
- Currently taking blood pressure medications, oral diabetic medication or insulin, or lipid medication
- Systolic blood pressure ≥160 and/or diastolic ≥100
- Unstable cardiac disease e.g. angina, life threatening arrhythmia
- Lung disease requiring oxygen supplementation at rest or with ambulation
- History of dementia or cognitive impairment
- Uncontrolled psychiatric disorders, such as major depression or psychosis
- Current participation in a mind-body practice/program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gurjeet Birdee, MD
Vanderbilt University Medical Center
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
September 6, 2016
First Posted
September 14, 2016
Study Start
June 1, 2013
Primary Completion
January 1, 2014
Study Completion
January 1, 2014
Last Updated
January 2, 2017
Record last verified: 2016-12
Data Sharing
- IPD Sharing
- Will not share